DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 215 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,436 | +2.6% | 842 | -10.2% | 0.00% | – |
| Q2 2023 | $12,119 | -59.1% | 938 | -68.9% | 0.00% | – |
| Q1 2023 | $29,607 | -14.5% | 3,018 | -7.3% | 0.00% | – |
| Q4 2022 | $34,633 | +147.4% | 3,255 | +141.5% | 0.00% | – |
| Q3 2022 | $14,000 | -39.1% | 1,348 | -25.6% | 0.00% | – |
| Q2 2022 | $23,000 | +15.0% | 1,813 | 0.0% | 0.00% | – |
| Q1 2022 | $20,000 | -23.1% | 1,813 | 0.0% | 0.00% | – |
| Q4 2021 | $26,000 | -33.3% | 1,813 | -11.9% | 0.00% | – |
| Q3 2021 | $39,000 | +95.0% | 2,058 | 0.0% | 0.00% | – |
| Q2 2021 | $20,000 | -16.7% | 2,058 | -13.4% | 0.00% | – |
| Q1 2021 | $24,000 | +166.7% | 2,377 | +15.5% | 0.00% | – |
| Q4 2020 | $9,000 | +200.0% | 2,058 | +195.3% | 0.00% | – |
| Q3 2020 | $3,000 | -50.0% | 697 | 0.0% | 0.00% | – |
| Q2 2020 | $6,000 | -87.0% | 697 | -71.1% | 0.00% | – |
| Q1 2016 | $46,000 | -20.7% | 2,415 | 0.0% | 0.00% | – |
| Q4 2015 | $58,000 | – | 2,415 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |